Veriheal

JUNE 30, 2023

To start, participants reported that psilocybin had helped them process emotions tied to painful events in their past. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

MAY 30, 2023

Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. This research involved monitoring the treatment responses of 358 adult cancer patients over 3.5 Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

JULY 28, 2021

Translating complex policy ideas into talking points, emails, briefs, and other publicly accessible communications. Collaborating with County departments, community leaders and other agencies to obtain data, provide analysis and convey results that support the Supervisor’s policy agenda. Skills And Experience Required.

Policy 105

Policy Legislation Research and Development Data 105

Cannabis Law Report

FEBRUARY 3, 2022

The Smart Event, comprising in-person and online platforms, to convene thousands of engineers, business leaders, disruptive companies, and innovative thinkers to design powerful solutions to today’s most pressing challenges. The online platform will open on March 14 and is accessible to all registered visitors. ANAHEIM, Calif.–(BUSINESS

Packaging 52

Packaging Events Education Supply Chain 52

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

Cannabis Law Report

SEPTEMBER 23, 2021

The major concerns noted were adverse events following consumption (many from inadvertent intoxication), marketing to and use by minors, and the potential presence of harmful by-products and unsafe manufacturing practices. The FDA has received adverse event reports involving delta-8 THC-containing products. CDC Health Alert.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JUNE 16, 2019

As the district attorneys for Albany County and Manhattan, it is our duty to uphold justice and public safety on behalf of our upstate and downstate communities. Cuomo and state legislators must correct staggering inequities and promote public safety by passing the Marijuana Revenue and Taxation Act. In the final days of session, Gov.

Legalization 55

Legalization Safety Legislation Decriminalization 55

Cannabis Law Report

JANUARY 23, 2022

Events like these afford us a glimpse into the future of research and medicine in this field. Seeing these results for the first time alongside qualitative data in the form of patient testimonies and images was an incredibly profound experience that is hard to replicate in a written format. Many variables impact the outcomes of GVHD.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

MassRoots

AUGUST 4, 2020

Cannabis businesses deserve the same access to banking and insurance services as any other legitimate business. We need SAFE Banking to ensure that BIPOC (Black, Indigenous, People of Color) owned businesses, especially women, have equitable access to funding and for the safety of our employees and our communities.

Banking 52

Banking Access Business Programs 52

NORML

MAY 24, 2019

The Rochester advocacy groups are hosting a series of community education and outreach events to mobilize support for immediately passing the Marijuana Regulation and Taxation Act (S.1527/A.1617), Safeguarding safety and public health through advertising restrictions, stringent quality control, harm reduction options, and public education.

Marijuana 103

Marijuana Education Advocacy Legislation 103

Cannabis Law Report

MARCH 19, 2020

They expressed this concern at a public meeting held by FDA in May 2019, explaining that conflicting regulatory requirements create uncertainty that is stifling medical research and hindering consumer access to CBD products. In particular, the report emphasizes that FDA continues to be concerned about potential safety risks (i.e.,

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Cannabis Law Report

JANUARY 13, 2020

commercial and government payors to ensure that appropriate patients have access to Epidiolex with as few restrictions as possible. Continue to explore CBDV in autism through a combination of open-label and investigator-led placebo controlled clinical trials with data from one or more of these programs in 2020. Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. MyMD Contact: Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

CannaMD

SEPTEMBER 15, 2020

MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies.

Law 126

Law Marijuana Patients Treatment 126

TheAnswerPage

JANUARY 11, 2022

As a result, state medical marijuana rules and regulations have focused on the demands of the public without putting significant emphasis on the scientific data or the ability of the medical community to support and care for medical marijuana patients. Available at: [link] Accessed 05 Dec. link] -Accessed December 5, 2021.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 95

Data Vaping Supply Chain Business 95

SpeedWeed

JULY 30, 2021

In my review of that book for Leafly , I charged Berenson with being a fundamentally dishonest writer, willing to purposefully and consistently distort data and provide false witness so long as it bolsters his central claim that cannabis is incredibly dangerous. So if you’re asking me where to turn for the hard data, I’d say start here.

Marijuana 52

Marijuana History Data Strains 52

SpeedWeed

APRIL 21, 2021

However, all is not lost as there are some “warm-up bands” on stage that have or will be issuing licenses before the big licensing events in NY, NJ, VA, and NM. Georgia’s Access to Medical Cannabis Commission received 70 applications for six production licenses. The oil has to be sourced out of state and patients needed a waiver.

Programs 52

Programs Dispensary Oil Cultivation 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Prior to joining Sesen Bio, Mr. Barbera served as the Vice President of Market Access at UroGen Pharma and played a critical role in the launch of the company’s first commercial product, Jelmyto ®. Sesen Bio remains committed to the health and safety of patients, caregivers and employees.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 12, 2021

At that time, several states already allowed qualified patients to access and use marijuana for medicinal purposes, but as a regulator, I would not have considered the banking challenges of the cannabis industry to be at the top of my list of concerns. .” Of course, that’s assuming I would have been invited in the first place.

Banking 89

Banking Law Legalization Hemp 89

Cannabis Law Report

DECEMBER 14, 2021

Columbia Care’s mission has always been to provide patients with access to the highest quality, safest medicinal cannabis products available. We are proud to leverage our proprietary IP, formulation expertise, safety surveillance and patient reported data from the U.S.

Extraction 52

Extraction Patients Medicine Tincture 52

The Herb Collective

APRIL 29, 2019

Delivery For Everybody Good news for everyone aged over 21 in California who wants to get their hands on legal cannabis – official codes have now been put in place to ensure that even people living in “ban towns” can access tested and taxed cannabis legally.

Law 45

Law Marijuana Banking Packaging 45

Cannabis Law Report

SEPTEMBER 24, 2019

We believe patients and physicians deserve access to rigorously tested and evaluated cannabis-based medicines, manufactured to the highest standards and approved by medicines regulators, and we are delighted to be the first to offer this solution to the epilepsy community.”. Forward-looking statements. All investor and media enquiries.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

CannaMD

DECEMBER 9, 2020

The AHA position paper then moves on to address a range of known, potential, and suggested safety concerns associated with cannabis use. The AHA statement raises questions on whether cannabis use plays a role in major cardiac events such as arrhythmia and heart attacks, but does not draw any definitive conclusions. for men, 1.3%

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

SpeedWeed

APRIL 28, 2021

Curaleaf also hosts panel discussions and support events for all team members: . increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission. And we also have access to our industry health and welfare funds as well. PRIDE/QUSH (Queer-Centered Unity and Service Huddle).

Seed-To-Sale 52

Seed-To-Sale Dispensary Cultivation Food 52

SpeedWeed

APRIL 28, 2021

Curaleaf also hosts panel discussions and support events for all team members: . increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission. And we also have access to our industry health and welfare funds as well. PRIDE/QUSH (Queer-Centered Unity and Service Huddle).

Legalization 52

Legalization Seed-To-Sale Dispensary Cannabis 52

SpeedWeed

APRIL 27, 2021

Curaleaf also hosts panel discussions and support events for all team members: . increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission. And we also have access to our industry health and welfare funds as well. PRIDE/QUSH (Queer-Centered Unity and Service Huddle).

Seed-To-Sale 52

Seed-To-Sale Dispensary Cannabis Cultivation 52

SpeedWeed

APRIL 29, 2021

Curaleaf also hosts panel discussions and support events for all team members: . increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission. And we also have access to our industry health and welfare funds as well. PRIDE/QUSH (Queer-Centered Unity and Service Huddle).

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

SpeedWeed

AUGUST 13, 2021

Safety also played a role in Holistic Industries’ decision to convert its indoor facilities to LEDs. When you increase temperature, it’s all a chain reaction of events,” Denney says. The post Texas Cancer Patients, Those With PTSD Gear Up For Medical Cannabis Access appeared first on SpeedWeed. ” View original article.

Access 52

Access Patients Banking Cultivation 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JANUARY 23, 2020

As such, the Bureau finds that immediate action to amend the Bureau’s regulations is required to avoid serious harm to the public peace, health, safety, and general welfare. Cannabis goods sold by unlicensed cannabis retailers do not have to meet the same consumer safety standards imposed during the testing process.

Vaping 64

Vaping THC Retail Safety 64

Peninsula Alternative Health

JUNE 12, 2023

This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry. The law includes provisions to ensure that registered patients continue to have access to their necessary medication, such as patient-only operating hours and product availability.

Legislation 52

Legislation Packaging Edibles Concentrates 52